D.E. Shaw & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.1M | Sell |
|
|||||
|
2025
Q2 | $33.9M | Buy |
|
|||||
|
2025
Q1 | $32.8M | Buy |
|
|||||
|
2024
Q4 | $7.36M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $265K | Sell |
|
|||||
|
2024
Q1 | $1.62M | Sell |
|
|||||
|
2023
Q4 | $3.61M | Buy |
|
|||||
|
2023
Q3 | $864K | Buy |
|
|||||
|
2023
Q2 | $1.29M | Sell |
|
|||||
|
2023
Q1 | $6.04M | Sell |
|
|||||
|
2022
Q4 | $44.5M | Buy |
|
|||||
|
2022
Q3 | $1.49M | Buy |
|
|||||
|
2022
Q2 | $1.59M | Sell |
|
|||||
|
2022
Q1 | $2.23M | Sell |
|
|||||
|
2021
Q4 | $2.75M | Sell |
|
|||||
|
2021
Q3 | $3.05M | Buy |
|
|||||
|
2021
Q2 | $2.09M | Buy |
|
|||||
|
2021
Q1 | $903K | Buy |
|
|||||
|
2020
Q4 | $424K | Buy |
|
|||||
|
2020
Q1 | – | Hold |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $247K | Sell |
|
|||||
|
2019
Q2 | $904K | Buy |
|
|||||
|
2019
Q1 | $361K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $336K | Sell |
|
|||||
|
2018
Q1 | $4.98M | Buy |
|
|||||
|
2017
Q4 | $2.29M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $64K | Sell |
|
|||||
|
2016
Q1 | $110K | Sell |
|
|||||
|
2015
Q4 | $283K | Buy |
|
|||||
|
2015
Q3 | $495K | Sell |
|
|||||
|
2015
Q2 | $941K | Buy |
|
|||||
|
2015
Q1 | $369K | Sell |
|
|||||
|
2014
Q4 | $947K | Sell |
|
|||||
|
2014
Q3 | $2.07M | Sell |
|
|||||
|
2014
Q2 | $3.95M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $1.26M | Sell |
|
|||||
|
2013
Q3 | $1.8M | Buy |
|
|||||
|
2013
Q2 | $295K | Buy |
|